| Q39033977 | A Perspective on the Safety of Supplemental Tryptophan Based on Its Metabolic Fates |
| Q22306143 | A Radiobiological Review on Melatonin: A Novel Radioprotector |
| Q34144992 | A pilot double-blind randomised placebo-controlled dose-response trial assessing the effects of melatonin on infertility treatment (MIART): study protocol |
| Q38250438 | A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases. |
| Q38212332 | A systematic review of peri-operative melatonin. |
| Q40086280 | Acute and delayed sulfur mustard toxicity; novel mechanisms and future studies |
| Q46692847 | Alleviation of maternal hyperthermia-induced early embryonic death by administration of melatonin to mice |
| Q46317625 | Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction. |
| Q37449701 | Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction--a phase I pilot clinical trial: study protocol |
| Q34402174 | Antiinflammatory activity of melatonin in central nervous system |
| Q34040006 | Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation |
| Q43596811 | Beneficial effect of melatonin on blastocyst in vitro production from heat-stressed bovine oocytes |
| Q99575524 | Central and Peripheral Actions of Melatonin on Reproduction in Seasonal and Continuous Breeding Mammals |
| Q34599621 | Comparison of the protective effects of melatonin and amifostine on radiation-induced epiphyseal injury |
| Q44405001 | Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern |
| Q37691012 | Developmental Programming of Adult Disease: Reprogramming by Melatonin? |
| Q33616780 | Dietary Sources and Bioactivities of Melatonin |
| Q43774249 | Effect of prenatal melatonin exposure on gonadotropins and prolactin secretion in male and female rat pups |
| Q83140555 | Effects of antenatal, postpartum and post-weaning melatonin supplementation on blood pressure and renal antioxidant enzyme activities in spontaneously hypertensive rats |
| Q53267049 | Effects of prenatal 900 MHz electromagnetic field exposures on the histology of rat kidney. |
| Q36696959 | Evidence supporting the use of melatonin in short gestation infants |
| Q38189699 | Extrapineal melatonin: sources, regulation, and potential functions. |
| Q92794063 | Fast-tracking regenerative medicine for traumatic brain injury |
| Q35006494 | Inhibition of cysteine proteases in acute and chronic spinal cord injury |
| Q43989274 | Inhibitory effect of melatonin on homocysteine-induced lipid peroxidation in rat brain homogenates. |
| Q38771820 | Intranasal melatonin nanoniosomes: pharmacokinetic, pharmacodynamics and toxicity studies. |
| Q57049117 | Maternal Melatonin Therapy Attenuates Methyl-Donor Diet-Induced Programmed Hypertension in Male Adult Rat Offspring |
| Q48113846 | Maternally administered melatonin differentially regulates lipopolysaccharide-induced proinflammatory and anti-inflammatory cytokines in maternal serum, amniotic fluid, fetal liver, and fetal brain |
| Q47909891 | Melatonin Improves Mitochondrial Respiration in Syncytiotrophoblasts From Placentas of Obese Women |
| Q64899186 | Melatonin Levels in Preterm and Term Infants and Their Mothers. |
| Q35925626 | Melatonin Supports CYP2D-Mediated Serotonin Synthesis in the Brain |
| Q47169877 | Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors |
| Q37202319 | Melatonin Treatment Improves Mesenchymal Stem Cells Therapy by Preserving Stemness during Long-term In Vitro Expansion. |
| Q34158377 | Melatonin and atopy: role in atopic dermatitis and asthma |
| Q37480368 | Melatonin and reproduction revisited |
| Q36689207 | Melatonin and sleep disorders associated with intellectual disability: a clinical review |
| Q26825609 | Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology |
| Q55051489 | Melatonin as a Therapy for Traumatic Brain Injury: A Review of Published Evidence. |
| Q37900675 | Melatonin as a natural ally against oxidative stress: a physicochemical examination. |
| Q55019660 | Melatonin as a new drug for improving oocyte quality. |
| Q42356205 | Melatonin as an adjuvant therapy in patients with rheumatoid arthritis |
| Q44099805 | Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model |
| Q37615464 | Melatonin effect during different maturation stages of oocyte and subsequent embryo development in mice |
| Q46971011 | Melatonin effect on bovine embryo development in vitro in relation to oxygen concentration. |
| Q54116564 | Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia. |
| Q48139622 | Melatonin enhances hyperthermia-induced apoptotic cell death in human leukemia cells |
| Q24188340 | Melatonin for preventing pre-eclampsia |
| Q24186076 | Melatonin for treating pre-eclampsia |
| Q24186003 | Melatonin for women in pregnancy for neuroprotection of the fetus |
| Q50664000 | Melatonin improves cerebrovascular function and decreases oxidative stress in chronically hypoxic lambs. |
| Q43930997 | Melatonin improves deferoxamine antioxidant activity in protecting against lipid peroxidation caused by hydrogen peroxide in rat brain homogenates |
| Q37302940 | Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel? |
| Q46641268 | Melatonin inhibits cholangiocarcinoma and reduces liver injury in Opisthorchis viverrini-infected and N-nitrosodimethylamine-treated hamsters |
| Q51682864 | Melatonin prevents neural tube defects in the offspring of diabetic pregnancy. |
| Q48631175 | Melatonin prevents postovulatory oocyte aging in the mouse and extends the window for optimal fertilization in vitro. |
| Q51023886 | Melatonin prolongs graft survival of pancreas allotransplants in pigs. |
| Q44792188 | Melatonin protects against piroxicam-induced gastric ulceration |
| Q46621107 | Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion |
| Q57817366 | Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep |
| Q36800145 | Melatonin rescues cardiovascular dysfunction during hypoxic development in the chick embryo |
| Q42610763 | Melatonin restores muscle regeneration and enhances muscle function after crush injury in rats. |
| Q33624824 | Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis |
| Q62071833 | Melatonin: A Versatile Protector against Oxidative DNA Damage |
| Q34014678 | Melatonin: an established antioxidant worthy of use in clinical trials. |
| Q36396126 | Melatonin: possible implications for the postoperative and critically ill patient |
| Q28917092 | Melatonin: shedding light on infertility?--A review of the recent literature |
| Q34323319 | Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome |
| Q57405344 | Neonatal hypoxic ischaemic encephalopathy: current and future treatment options |
| Q35037632 | New antioxidant drugs for neonatal brain injury. |
| Q36374839 | New horizons for newborn brain protection: enhancing endogenous neuroprotection |
| Q34119118 | Oxidative stress-mediated aging during the fetal and perinatal periods. |
| Q33316181 | PORTAL: pilot study on the safety and tolerance of preoperative melatonin application in patients undergoing major liver resection: a double-blind randomized placebo-controlled trial |
| Q36820433 | Peripheral reproductive organ health and melatonin: ready for prime time |
| Q49351519 | Phase I Pilot Clinical Trial of Antenatal Maternally Administered Melatonin to Decrease the Level of Oxidative Stress in Human Pregnancies Affected by Preeclampsia |
| Q37190390 | Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol |
| Q28073105 | Phenolic Melatonin-Related Compounds: Their Role as Chemical Protectors against Oxidative Stress |
| Q37873941 | Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period |
| Q44604283 | Protective effect of melatonin against fractionated irradiation‐induced epiphyseal injury in a weanling rat model |
| Q46888694 | Protective effects of exogenously administered or endogenously produced melatonin on hyperbaric oxygen-induced oxidative stress in the rat brain |
| Q51116612 | Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats. |
| Q90330521 | Protective effects of melatonin and omega-3 on the hippocampus and the cerebellum of adult Wistar albino rats exposed to electromagnetic fields |
| Q38191261 | Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review |
| Q35369354 | Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats. |
| Q93211797 | Rapid Communication: Maternal melatonin implants improve fetal oxygen supply and body weight at term in sheep pregnancies |
| Q36790506 | Roles of melatonin in fetal programming in compromised pregnancies. |
| Q37049982 | Supplementation with low concentrations of melatonin improves nuclear maturation of human oocytes in vitro |
| Q58769072 | The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation |
| Q38675828 | The Safety of Melatonin in Humans |
| Q35753913 | The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial |
| Q36831068 | The effect of preoperative melatonin on nuclear erythroid 2-related factor 2 activation in patients undergoing coronary artery bypass grafting surgery |
| Q36277582 | The fetal origins of the metabolic syndrome: can we intervene? |
| Q33823742 | The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors |
| Q52147437 | The neuroprotective and anti-apoptotic effects of melatonin on hemolytic hyperbilirubinemia-induced oxidative brain damage. |
| Q35812131 | The role of melatonin as an antioxidant in the follicle |
| Q45773544 | The use of high-dose melatonin in liver resection is safe: first clinical experience |
| Q51351946 | Therapeutic efficacy of melatonin in reducing retinal damage in an experimental model of early type 2 diabetes in rats. |
| Q46800761 | Utility of melatonin to treat surgical stress after major vascular surgery--a safety study |
| Q36021253 | When melatonin gets on your nerves: its beneficial actions in experimental models of stroke |
| Q33723452 | Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? |